Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Glycaemic Index of Manuka Honey

This study has been completed.
Sponsor:
Collaborator:
Manuka Health NZ Ltd
Information provided by (Responsible Party):
Dr Lynne Chepulis, Waiariki Institute of Technology
ClinicalTrials.gov Identifier:
NCT01615588
First received: June 6, 2012
Last updated: June 7, 2012
Last verified: June 2012

June 6, 2012
June 7, 2012
April 2012
April 2012   (final data collection date for primary outcome measure)
Determine the Glycaemic index of Manuka honey [ Time Frame: 2 weeks ] [ Designated as safety issue: No ]
10 healthy individuals consumed honey (25g of available carbohydrate in 200 ml of water) in a fasted state. Blood glucose levels were recorded at 0, 15, 30, 45, 60, 90 and 120 mins and the area under the blood glucose curve was calculated. All 10 participants took five different honeys and a glucose standard on six different days (with randomised allocation of samples).
Same as current
Complete list of historical versions of study NCT01615588 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Glycaemic Index of Manuka Honey
The Glycaemic Index of Manuka Honey

Five high methylglyoxal (460-667 mg/kg) Manuka honey samples were selected from different geographical locales around the North Island of New Zealand and tested for glycaemic index (GI) in 10 healthy volunteers in a single-blinded, randomised study. Participants were fed honey containing 25g of available carbohydrate in 200 ml water and the blood glucose responses measured (area under the curve; AUC) and compared to that of 25 g of available carbohydrate from glucose.

Not Provided
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Basic Science
Healthy
Dietary Supplement: Manuka Honey
honey was weighed out to provide 25 g of available carbohydrate in 200 ml of water
Other Name: Manuka Health New Zealand Manuka honey
Experimental: honey
Manuka honey
Intervention: Dietary Supplement: Manuka Honey
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
10
April 2012
April 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • healthy (Body mass index (BMI) 20-25)
  • non-smoking
  • aged between 18-45 years
  • absence of diabetes or chronic illness
  • not taking any medications.

Exclusion Criteria:

  • currently dieting
  • suffering from illness or chronic disease
  • currently taking medication
  • smokers (including recreational)
  • outside healthy BMI range
Both
18 Years to 45 Years
Yes
Contact information is only displayed when the study is recruiting subjects
New Zealand
 
NCT01615588
Manuka GI Study
Yes
Dr Lynne Chepulis, Waiariki Institute of Technology
Waiariki Institute of Technology
Manuka Health NZ Ltd
Not Provided
Waiariki Institute of Technology
June 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP